ym 09151-2 has been researched along with 1-(3,4-dimethoxyphenethyl)-4-(3-phenylpropyl)piperazine dihydrochloride in 1 studies
Studies (ym 09151-2) | Trials (ym 09151-2) | Recent Studies (post-2010) (ym 09151-2) | Studies (1-(3,4-dimethoxyphenethyl)-4-(3-phenylpropyl)piperazine dihydrochloride) | Trials (1-(3,4-dimethoxyphenethyl)-4-(3-phenylpropyl)piperazine dihydrochloride) | Recent Studies (post-2010) (1-(3,4-dimethoxyphenethyl)-4-(3-phenylpropyl)piperazine dihydrochloride) |
---|---|---|---|---|---|
249 | 6 | 13 | 113 | 2 | 41 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ishiwata, K; Kawamura, K; Kobayashi, T; Matsuno, K | 1 |
1 other study(ies) available for ym 09151-2 and 1-(3,4-dimethoxyphenethyl)-4-(3-phenylpropyl)piperazine dihydrochloride
Article | Year |
---|---|
Sigma1 and dopamine D2 receptor occupancy in the mouse brain after a single administration of haloperidol and two dopamine D2-like receptor ligands.
Topics: Animals; Benzamides; Brain; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Drug Interactions; Haloperidol; Injections, Intraperitoneal; Ligands; Male; Mice; Nootropic Agents; Piperazines; Raclopride; Receptors, Dopamine D2; Receptors, sigma | 2003 |